ACUTE AND SUBACUTE TOXICITY STUDIES OF POLYHERBAL FORMULATION OF TALISADYA CHURNA IN EXPERIMENTAL ANIMAL MODEL

  • Parag Jain M.Pharm, PDCR, Assistant Professor, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya, Bilaspur, India 495009
  • Ravindra Pandey M.Pharm, Ph.D, Associate Professor, Columbia Institute of Pharmacy, Raipur, India 492001
  • Shiv Shankar Shukala shivpharma007@gmail.com

Abstract

Ethnopharmacological relevance: Talisadya churna includes several herbal drugs which have been traditionally by ethnic groups for treating vomiting, flatulence with gurgling sound, cough, asthma, fever, anorexia, indigestion, diarrhoea, cachexia, splenic disease, malabsorption syndrome and anaemia.

Object: The present study investigated the acute and sub-acute toxicity of Talisadya churna, a polyherbal formulation, in experimental animal models.

Material and methods: In an acute toxicity study, Talisadya churna was administered orally at groups of animals of a single sex are dosed in a stepwise procedure using the fixed doses of 5, 50, 300 and 2000 mg/kg a period of at least 24 hours were allowed between the dosing of each animal and then were observed for 14 days.

Result: The results indicated there were no toxic symptoms up to the dose level of 2000 mg/kg p.o. In a subacute toxicity study, Talisadya churna was tested at different dose level of 250, 500 and 1000 mg/kg p.o. once daily for 28 days. There were no adverse effects on general condition, growth, feed and water consumption, clinical chemistry values and hematological parameters. The vital organs of animals treated with Talisadya churna for 28 days did not show any histopathological evidence of pathological lesions.

Conclusion: The result obtained in this study allowed us to conclude that the Talisadya 

Author Biographies

Parag Jain, M.Pharm, PDCR, Assistant Professor, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya, Bilaspur, India 495009
M.Pharm, PDCR, Assistant Professor, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya, Bilaspur, India 495009
Ravindra Pandey, M.Pharm, Ph.D, Associate Professor, Columbia Institute of Pharmacy, Raipur, India 492001
M.Pharm, Ph.D, Associate Professor, Columbia Institute of Pharmacy, Raipur, India 492001 
Shiv Shankar Shukala, shivpharma007@gmail.com

shivpharma007@gmail.com

References

Karta Purkh Singh Khalsa, Michael Tierra, 2008, The Way of Ayurvedic Herbs: The Most Complete Guide to Natural Healing and Health with Traditional Ayurvedic Herbalism, First edition, 214

Salavurao Gopal, 2007, Principles & Practices of Ayurvedic Medicine, Chaukhamba Publications, First edition, 165

Arun Kumar Sethi, 2011, Combating Allergy Naturally, V and S publishers, Edition: April 2011, 85-88

The Ayurvedic Pharmacopoeia of India (API), 2007, (A.F.I), Part-2 (Formulations), Volume-1, First Edition, Page-57

S. S. Shukla, S. Saraf, S. Saraf, 2009, Development of spectrophotometric fingerprinting method for Talisadi Churna, East and Central African Journal of Pharmaceutical Sciences, Vol. 12, 52-54

The Organisation of Economic Cooperation and Development (OECD), 2001a The OECD Guidelines for testing of chemicals: 420 Acute Oral Toxicity, Paris, 1-7

The Organisation of Economic Cooperation and Development (OECD), 2001a The OECD Guidelines for testing of chemicals: 407 Repeated Dose Oral Toxicity-Rodent: 28-Day or 14-Day Study. OECD, Paris, 1-7.

Published
2015-02-15
How to Cite
Jain, P., Pandey, R., & Shukala, S. S. (2015). ACUTE AND SUBACUTE TOXICITY STUDIES OF POLYHERBAL FORMULATION OF TALISADYA CHURNA IN EXPERIMENTAL ANIMAL MODEL. Mintage Journal of Pharmaceutical and Medical Sciences (ISSN: 2320-3315), 7-10. Retrieved from http://mjpms.in/index.php/mjpms/article/view/66